Skip to Content

  • Search

View Additional Section Content

ALIAS Part 2 – Albumin in Acute Stroke - A Phase III Randomized Multicenter Clinical Trial of High-Dose Human Albumin Therapy for Neuroprotection in Acute Ischemic Stroke

Principal Investigator(s)
David Weisman, M.D.
Brad Klein, M.D. (Sub-Investigator)
Dan J. Gzesh, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Stroke Research
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details